시장보고서
상품코드
1940936

안구건조증 치료 장치 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2033년)

Dry Eye Disease Treatment Devices Market Insights, Competitive Landscape, and Market Forecast - 2033

발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 193 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 안구건조증 치료 장치 시장은 눈 질환 증가 및 눈 건강에 대한 의식의 고조를 배경으로 견조한 성장을 보이고 있습니다. 시장 예측에 따르면 2026년 3,401억 달러에 이를 전망이고, CAGR 5.20%로 확대될 것으로 예측되며, 2033년에는 5,587억 달러에 이를 것으로 전망되고 있습니다. 눈물 분비 부족 또는 과도한 눈물 증발로 인한 안구건조증은 삶의 질에 심각한 영향을 미치므로 효과적인 치료 솔루션이 긴급한 과제가 되고 있습니다. 첨단 치료 장비는 병원, 안과 진료소, 외과 시설에서 보급이 진행되고 있으며 환자에게 약물 요법에 의존하지 않는 표적을 좁힌 치료 옵션을 제공합니다.

시장 인사이트

안구건조증 치료 장치 시장은 기술 혁신 및 환자 의식 증가를 배경으로 빠르게 진화하고 있습니다. Mybom 땀샘의 막힘 제거 시스템, 눈물 플러그, 눈통 완화 기구 등의 장비는 치료 성과 향상과 환자 컴플라이언스 향상에 기여하고 있습니다. 게다가, 저침습 요법의 도입은 기존 약물에 대한 의존도를 감소시키고, 보다 신속한 증상 완화 및 우수한 장기적인 치료 효과를 기대합니다. 디지털 진단, 인공지능 및 원격 의료 솔루션의 통합은 개인화된 치료와 지속적인 모니터링을 가능하게 하고 치료 최적화를 더욱 진행하고 있습니다.

의료 제공업체가 환자 중심의 솔루션에 주력하는 가운데, 효율성, 안전성, 편리성을 겸비한 선진 기기에 대한 수요가 꾸준히 증가하고 있습니다. 주요 업계 진출 기업에 의한 연구개발 투자는 혁신적인 치료 솔루션을 지속적으로 만들어 시장의 지속적인 성장을 추진하고 있습니다.

시장 성장 촉진요인

안구건조증 치료 장치 시장의 확대를 견인하는 요인은 다음과 같습니다.

  • 1. 안구건조증의 유병률 상승 : 스크린 시간 증가, 고령화, 환경 요인이 세계적으로 안구건조증의 발생률 상승에 기여하고 있습니다.
  • 2. 기술 혁신 : 열 펄세이션 시스템, 마이크로 브레비아로 엑소피에이션 툴, 눈물 플러그 등의 첨단 장치가 안구건조증 증상의 효과적인 관리를 실현하고 있습니다.
  • 3. 인지도 향상 및 조기 진단 : 환자와 의료 종사자 사이에서 조기 발견 및 조기 치료의 중요성이 높아지고 있어 전문 기기에 대한 수요가 증가하고 있습니다.
  • 4. 비약물 요법에 대한 지향 : 종래의 약제에 비해 부작용이 적고, 복약 준수가 향상되고 증상 완화가 신속하기 때문에 디바이스를 이용한 치료법이 주목을 받고 있습니다.
  • 5. 의료비 지출 증가 : 안과 의료 인프라 및 안과 케어 서비스에 대한 투자는 혁신적인 안구건조증 치료 장치의 도입을 지원합니다.

비즈니스 기회

안구건조증 치료 장치 시장은 기존 기업과 신흥 기업 모두에게 큰 기회를 제공합니다. 효과적이고 저침습, 환자 친화적인 혁신적인 장치에 대한 수요가 증가하고 있습니다. 첨단 안과 의료에 대한 인지도와 접근성이 향상된 신흥 경제국으로의 진출은 중요한 성장 경로가 될 것입니다.

전략적 제휴, 합병 및 인수는 시장 통합을 촉진하고 제품 포트폴리오를 강화하며 지역적 확대를 지원할 것으로 예측됩니다. 디지털 모니터링, 원격 의료 및 스마트 치료 플랫폼의 통합은 또한 장치 제조업체가 종합적인 환자 관리를 제공할 수 있는 새로운 기회를 제공합니다. 연구 주도형으로 기술을 활용한 솔루션에 주력하는 기업이 경쟁 우위성을 획득할 가능성이 높습니다.

지역별 분석

세계 시장은 지역마다 다른 성장을 보여줍니다.

  • 북미 : 고급 의료 인프라, 환자의 높은 인식, 주요 장비 제조업체의 강력한 존재감으로 시장을 선도하고 있습니다. 유리한 규제 프레임워크가 도입을 더욱 강화하고 있습니다.
  • 유럽 : 고령화, 안구건조증의 높은 유병률 및 장치 기반 치료를 지원하는 상환 정책으로 꾸준한 성장을 보여줍니다.
  • 아시아태평양 : 중국, 인도, 일본 등 국가에서 디지털 기기 이용 증가, 의료 투자 확대, 의식 증가 등을 바탕으로 가장 빠른 성장이 예상됩니다.
  • 라틴아메리카 : 의료 인프라 확장 및 고급 안과 치료의 도시 지역에 대한 보급이 성장을 이끌고 있습니다.
  • 중동 및 아프리카 : 시장은 개발 도상에 있지만, 계발 캠페인, 정부 주도 노력, 전문 안과 의료 서비스에 대한 수요 증가를 통해 성장 가능성을 갖고 있습니다.

주요 기업

안구건조증 치료 장치 시장 경쟁 구도는 제품 혁신, 제휴, 시장 확대에 주력하는 주요 기업별로 형성되어 있습니다. 주요 시장 진출기업은 다음과 같습니다.

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • 기타

이러한 기업들은 시장에서의 지위를 강화하고 세계 환자들에게 최첨단 솔루션을 제공하기 위해 조사, 신제품 출시, 지역 확대 전략에 투자하고 있습니다.

세분화

안구건조증 치료 장치 시장은 유형, 원인, 용도, 최종 사용자, 지역별 시장 세분화됩니다.

유형별

  • Mybom 땀샘 막힘 제거 시스템
  • 눈물 폐쇄 장치
  • 통증 완화 장치
  • 기타

원인별

  • 특발성
  • 희귀질환
  • 수술 수술
  • 약 섭취 관련
  • 디지털 노출
  • 노화

용도별

  • 수분 부족
  • 증발

최종 사용자별

  • 병원
  • 안과 센터
  • 외래수술센터(ASC)
  • 기타

지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의 및 세분화
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 밸류체인 분석
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
  • 러시아와 우크라이나 분쟁의 영향
  • PESTLE 분석
  • 규제 분석
  • 가격 동향 분석
    • 현재의 가격 및 장래 예측(2025-2033년)
    • 가격 영향요인

제3장 세계의 안구건조증 치료 장치 시장 전망(2020-2033년)

  • 세계의 안구건조증 치료 장치 시장 전망 : 유형별, 금액(10억 달러)(2020-2033년)
    • Mybom 땀샘 막힘 제거 시스템
    • 눈물 폐쇄 장치
    • 통증 완화 장치
    • 기타
  • 세계의 안구건조증 치료 장치 시장 전망 : 원인별, 금액(10억 달러)(2020-2033년)
    • 특발성
    • 희귀질환
    • 수술 수술
    • 약 섭취 관련
    • 디지털 노출
    • 노화
  • 세계의 안구건조증 치료 장치 시장 전망 : 용도별, 금액(10억 달러)(2020-2033년)
    • 수분 부족
    • 증발
  • 세계의 안구건조증 치료 장치 시장 전망 : 최종 사용자별, 금액(10억 달러)(2020-2033년)
    • 병원
    • 안과 센터
    • 외래수술센터(ASC)
    • 기타
  • 세계의 안구건조증 치료 장치 시장 전망 : 지역별, 금액(10억 달러)(2020-2033년)
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제4장 북미의 안구건조증 치료 장치 시장 전망(2020-2033년)

제5장 유럽의 안구건조증 치료 장치 시장 전망(2020-2033년)

제6장 아시아태평양의 안구건조증 치료 장치 시장 전망(2020-2033년)

제7장 라틴아메리카의 안구건조증 치료 장치 시장 전망(2020-2033년)

제8장 중동 및 아프리카의 안구건조증 치료 장치 시장 전망(2020-2033년)

제9장 경쟁 구도

  • 기업 대 부문 히트맵
  • 기업의 시장 점유율 분석(2025년)
  • 경쟁 대시보드
  • 기업 프로파일
    • Alcon Vision LLC
    • Johnson and Johnson Services Inc
    • AbbVie Inc.
    • Lumenis Be Ltd
    • ESW - Vision
    • MiBo Medical Group
    • Sight Sciences
    • Eyedetec Medical Inc.
    • BlephEx
    • NuSight Medicals- NuLids LLC

제10장 부록

AJY 26.03.03

The global Dry Eye Disease (DED) Treatment Devices Market is witnessing robust growth, driven by increasing prevalence of ocular disorders and rising awareness of eye health. According to market projections, the market is expected to reach USD 558.7 billion by 2033, growing from USD 340.1 billion in 2026, at a compound annual growth rate (CAGR) of 5.20%. Dry eye disease, a condition caused by insufficient tear production or excessive tear evaporation, significantly impacts quality of life, making effective treatment solutions a critical need. Advanced treatment devices are gaining traction across hospitals, eye care centers, and surgical facilities, providing targeted, non-pharmacological options for patients.

Market Insights

The DED treatment devices market is evolving rapidly, fueled by technological innovation and growing patient awareness. Devices such as meibomian gland unclogging systems, punctal plugs, and ocular pain-relieving instruments are improving treatment outcomes and enhancing patient compliance. In addition, the adoption of minimally invasive therapies is reducing dependence on traditional medications while offering faster relief and better long-term results. Integration of digital diagnostics, artificial intelligence, and telemedicine solutions is further optimizing treatment by enabling personalized care and continuous monitoring.

As healthcare providers increasingly focus on patient-centric solutions, the market is witnessing a steady rise in demand for advanced devices that combine efficacy, safety, and convenience. Research and development investments by key industry players are continuously introducing innovative treatment solutions, positioning the market for sustained growth.

Market Drivers

Several factors are driving the expansion of the DED treatment devices market:

  • 1. Rising Prevalence of Dry Eye Disease: Increasing screen time, aging populations, and environmental factors are contributing to higher incidence of dry eye disease globally.
  • 2. Technological Innovation: Advanced devices such as thermal pulsation systems, microblepharoexfoliation tools, and punctal plugs provide effective management of dry eye symptoms.
  • 3. Growing Awareness and Early Diagnosis: Patients and clinicians are increasingly prioritizing early detection and treatment, creating higher demand for specialized devices.
  • 4. Preference for Non-Pharmacological Treatments: Device-based therapies are gaining traction due to fewer side effects, improved compliance, and faster symptomatic relief compared to conventional medications.
  • 5. Rising Healthcare Expenditure: Investments in ophthalmology infrastructure and eye care services support the adoption of innovative DED treatment devices.

Business Opportunities

The DED treatment devices market presents significant opportunities for both established companies and emerging players. Innovative devices that are effective, minimally invasive, and patient-friendly are in high demand. Expanding into emerging economies, where awareness and access to advanced eye care are improving, represents a key growth avenue.

Strategic partnerships, mergers, and acquisitions are expected to drive market consolidation, enhance product portfolios, and support regional expansion. The integration of digital monitoring, telehealth, and smart treatment platforms also offers new opportunities for device manufacturers to provide comprehensive patient care. Companies that focus on research-driven, technology-enabled solutions are likely to gain a competitive edge.

Regional Analysis

The global market demonstrates varied growth across regions:

  • North America: Leads the market due to advanced healthcare infrastructure, high patient awareness, and strong presence of key device manufacturers. Favorable regulatory frameworks further support adoption.
  • Europe: Exhibits steady growth driven by an aging population, high prevalence of dry eye disease, and reimbursement policies supporting device-based therapies.
  • Asia Pacific: Expected to record the fastest growth, fueled by increased digital device usage, growing healthcare investment, and rising awareness in countries like China, India, and Japan.
  • Latin America: Growth is driven by expanding healthcare infrastructure and urban adoption of advanced ophthalmic treatments.
  • Middle East & Africa: The market is emerging, with growth potential through awareness campaigns, government initiatives, and rising demand for specialized eye care services.

Key Players

The competitive landscape of the DED treatment devices market is shaped by major players focused on product innovation, partnerships, and market expansion. Prominent participants include:

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • Others

These companies are investing in research, new product launches, and regional expansion strategies to strengthen their market position and deliver cutting-edge solutions to patients globally.

Segmentation

The DED treatment devices market is segmented by type, cause, application, end users, and region:

By Type

  • Meibomian Gland Unclogging Devices
  • Punctual Occlusion Devices
  • Pain-Reliving Devices
  • Others

By Cause

  • Idiopathic
  • Rare Diseases
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Aqueous Deficient
  • Evaporative

By End Users

  • Hospitals
  • Eye Care Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 3.1. Global Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Meibomian Gland Unclogging Devices
    • 3.1.2. Punctual Occlusion Devices
    • 3.1.3. Pain-Reliving Devices
    • 3.1.5. Others
  • 3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 3.2.1. Idiopathic
    • 3.2.2. Rare Diseases
    • 3.2.3. Surgery
    • 3.2.4. Drug Intake Associated
    • 3.2.5. Digital Exposure
    • 3.2.6. Age-Related
  • 3.3. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Aqueous Deficient
    • 3.3.2. Evaporative
  • 3.4. Global Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Eye Care Centers
    • 3.4.3. Ambulatory Surgical Centers
    • 3.4.4. Others
  • 3.5. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 4.1. North America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Meibomian Gland Unclogging Devices
    • 4.1.2. Punctual Occlusion Devices
    • 4.1.3. Pain-Reliving Devices
    • 4.1.5. Others
  • 4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 4.2.1. Idiopathic
    • 4.2.2. Rare Diseases
    • 4.2.3. Surgery
    • 4.2.4. Drug Intake Associated
    • 4.2.5. Digital Exposure
    • 4.2.6. Age-Related
  • 4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Aqueous Deficient
    • 4.3.2. Evaporative
  • 4.4. North America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Eye Care Centers
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Others
  • 4.5. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 4.5.2. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 4.5.3. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 4.5.4. U.S. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 4.5.5. Canada Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 4.5.6. Canada Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 4.5.7. Canada Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 4.5.8. Canada Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Meibomian Gland Unclogging Devices
    • 5.1.2. Punctual Occlusion Devices
    • 5.1.3. Pain-Reliving Devices
    • 5.1.5. Others
  • 5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 5.2.1. Idiopathic
    • 5.2.2. Rare Diseases
    • 5.2.3. Surgery
    • 5.2.4. Drug Intake Associated
    • 5.2.5. Digital Exposure
    • 5.2.6. Age-Related
  • 5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Aqueous Deficient
    • 5.3.2. Evaporative
  • 5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Eye Care Centers
    • 5.4.3. Ambulatory Surgical Centers
    • 5.4.4. Others
  • 5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.2. Germany Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.3. Germany Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.4. Germany Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.5. Italy Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.6. Italy Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.7. Italy Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.8. Italy Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.9. France Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.10. France Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.11. France Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.12. France Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.13. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.14. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.15. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.16. U.K. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.17. Spain Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.18. Spain Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.19. Spain Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.20. Spain Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.21. Russia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.22. Russia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.23. Russia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.24. Russia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 5.5.25. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 5.5.26. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 5.5.27. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 5.5.28. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Meibomian Gland Unclogging Devices
    • 6.1.2. Punctual Occlusion Devices
    • 6.1.3. Pain-Reliving Devices
    • 6.1.5. Others
  • 6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 6.2.1. Idiopathic
    • 6.2.2. Rare Diseases
    • 6.2.3. Surgery
    • 6.2.4. Drug Intake Associated
    • 6.2.5. Digital Exposure
    • 6.2.6. Age-Related
  • 6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Aqueous Deficient
    • 6.3.2. Evaporative
  • 6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Eye Care Centers
    • 6.4.3. Ambulatory Surgical Centers
    • 6.4.4. Others
  • 6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.2. China Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.3. China Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.4. China Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.5. Japan Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.6. Japan Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.7. Japan Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.8. Japan Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.9. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.10. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.11. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.12. South Korea Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.13. India Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.14. India Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.15. India Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.16. India Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.17. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.18. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.19. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.20. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 6.5.21. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 6.5.22. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 6.5.23. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 6.5.24. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Meibomian Gland Unclogging Devices
    • 7.1.2. Punctual Occlusion Devices
    • 7.1.3. Pain-Reliving Devices
    • 7.1.5. Others
  • 7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 7.2.1. Idiopathic
    • 7.2.2. Rare Diseases
    • 7.2.3. Surgery
    • 7.2.4. Drug Intake Associated
    • 7.2.5. Digital Exposure
    • 7.2.6. Age-Related
  • 7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Aqueous Deficient
    • 7.3.2. Evaporative
  • 7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Eye Care Centers
    • 7.4.3. Ambulatory Surgical Centers
    • 7.4.4. Others
  • 7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.2. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.3. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.4. Brazil Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.5. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.6. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.7. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.8. Mexico Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.9. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.10. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.11. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.12. Argentina Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 7.5.13. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 7.5.14. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 7.5.15. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 7.5.16. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Meibomian Gland Unclogging Devices
    • 8.1.2. Punctual Occlusion Devices
    • 8.1.3. Pain-Reliving Devices
    • 8.1.5. Others
  • 8.2. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Bn), 2020-2033
    • 8.2.1. Idiopathic
    • 8.2.2. Rare Diseases
    • 8.2.3. Surgery
    • 8.2.4. Drug Intake Associated
    • 8.2.5. Digital Exposure
    • 8.2.6. Age-Related
  • 8.3. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Aqueous Deficient
    • 8.3.2. Evaporative
  • 8.4. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Bn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Eye Care Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others
  • 8.5. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.2. GCC Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.3. GCC Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.4. GCC Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.5. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.6. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.7. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.8. South Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.9. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.10. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.11. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.12. Egypt Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.13. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.14. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.15. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.16. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
    • 8.5.17. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Type, 2020-2033
    • 8.5.18. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2020-2033
    • 8.5.19. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Application, 2020-2033
    • 8.5.20. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Alcon Vision LLC
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Johnson and Johnson Services Inc
    • 9.4.3. AbbVie Inc.
    • 9.4.4. Lumenis Be Ltd
    • 9.4.5. ESW - Vision
    • 9.4.6. MiBo Medical Group
    • 9.4.7. Sight Sciences
    • 9.4.8. Eyedetec Medical Inc.
    • 9.4.9. BlephEx
    • 9.4.10. NuSight Medicals- NuLids LLC

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제